Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) Operating Expenses (2016 - 2025)

Bruker (BRKR) has disclosed Operating Expenses for 16 consecutive years, with $372.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 11.47% year-over-year to $372.9 million, compared with a TTM value of $1.5 billion through Dec 2025, up 8.1%, and an annual FY2025 reading of $1.5 billion, up 8.1% over the prior year.
  • Operating Expenses was $372.9 million for Q4 2025 at Bruker, down from $431.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $431.2 million in Q3 2025 and bottomed at $189.6 million in Q1 2021.
  • Average Operating Expenses over 5 years is $282.6 million, with a median of $256.3 million recorded in 2023.
  • The sharpest move saw Operating Expenses skyrocketed 39.12% in 2023, then fell 11.47% in 2025.
  • Year by year, Operating Expenses stood at $216.2 million in 2021, then grew by 8.65% to $234.9 million in 2022, then soared by 39.12% to $326.8 million in 2023, then grew by 28.89% to $421.2 million in 2024, then fell by 11.47% to $372.9 million in 2025.
  • Business Quant data shows Operating Expenses for BRKR at $372.9 million in Q4 2025, $431.2 million in Q3 2025, and $346.0 million in Q2 2025.